Literature DB >> 1165554

Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.

H G Sheffield, M L Melton.   

Abstract

Rhesus monkey kidney cell cultures were inoculated with Toxoplasma gondii organisms obtained from peritoneal fluid of mice infected with the RH strain. Pyrimethamine and sulfadiazine were added either singly or in combination to the cultures 4 hr after inoculation. Twenty-four hours later the effect of the drugs on the parasites were studied by light and electron microscopy. Pyrimethamine (1.0 mug/ml) inhibited multiplication of the parasites and caused striking morphological changes. Organisms were rounded and often had a fragmented nucleus. Division was inhibited as indicated by abnormal daughter membrane formation during endodyogeny. No effect was evident in sulfadiazine-treated parasites when concentrations up to 50 mug/ml were used. However, combination of ineffective levels of pyrimethamine (0.1 mug/ml) and sulfadiazine (0.5 mug/ml) produced effects similar to those seen at a higher concentration of pyrimethamine indicating a synergistic action of the 2 drugs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165554

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  8 in total

1.  Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.

Authors:  M Wallon; C Liou; P Garner; F Peyron
Journal:  BMJ       Date:  1999-06-05

2.  In vitro effects of folate inhibitors on Toxoplasma gondii.

Authors:  F Derouin; C Chastang
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.

Authors:  E Schoondermark-van de Ven; J Galama; T Vree; W Camps; I Baars; T Eskes; J Meuwissen; W Melchers
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.

Authors:  B T Nguyen; S Stadtsbaeder
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 5.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

6.  In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.

Authors:  H R Chang; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.

Authors:  E Schoondermark-van de Ven; T Vree; W Melchers; W Camps; J Galama
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

8.  Toxoplasma modifies macrophage phagosomes by secretion of a vesicular network rich in surface proteins.

Authors:  L D Sibley; J L Krahenbuhl; G M Adams; E Weidner
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.